Effects of TO 194 on protein expression in patients with seasonal allergic rhinitis caused by Japanese cedar.
Phase of Trial: Phase II
Latest Information Update: 05 Jan 2011
At a glance
- Drugs Japanese cedar pollen allergy immunotherapy Torii Pharmaceutical (Primary)
- Indications Seasonal allergic rhinitis
- Focus Biomarker; Pharmacodynamics
- 05 Jan 2011 New trial record
- 30 Aug 2010 Results presented in the Journal of Allergy and Clinical Immunology.